Search results for the GEO ID: GSE29680
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM735987
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 1 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735988
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 2 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735989
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 3 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735990
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 4 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735992
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 7 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735993
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 8 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735994
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 9 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735995
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 10 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735996
GPL201
blood mononuclear leukocytes-before n-3 fatty acid suppl patient 11 Human blood mononuclear leukocytes before n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline N3 FA group
GSM735997
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 1 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM735998
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 2 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM735999
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 3 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736000
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 4 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736001
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 5 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736002
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 6 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736003
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 7 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736004
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 8 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736005
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 9 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736006
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 10 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736007
GPL201
blood mononuclear leukocytes-after 6 mo of n-3 fatty acid suppl patient 11 Human blood mononuclear leukocytes after 6 mo of n-3 fatty acid supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of n-3 fatty acid supplementation mononuclear leukocytes treated 6mo N3 FA group
GSM736008
GPL201
blood mononuclear leukocytes-before placebo suppl patient 12 Human blood mononuclear leukocytes before placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline Placebo group
GSM736009
GPL201
blood mononuclear leukocytes-before placebo suppl patient 13 Human blood mononuclear leukocytes before placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline Placebo group
GSM736010
GPL201
blood mononuclear leukocytes-before placebo suppl patient 14 Human blood mononuclear leukocytes before placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline Placebo group
GSM736011
GPL201
blood mononuclear leukocytes-before placebo suppl patient 15 Human blood mononuclear leukocytes before placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline Placebo group
GSM736012
GPL201
blood mononuclear leukocytes-before placebo suppl patient 16 Human blood mononuclear leukocytes before placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: none mononuclear leukocytes baseline Placebo group
GSM736013
GPL201
blood mononuclear leukocytes-after 6 mo of placebo suppl patient 12 Human blood mononuclear leukocytes after 6 mo of placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of placebo supplementation mononuclear leukocytes treated 6mo Placebo group
GSM736015
GPL201
blood mononuclear leukocytes-after 6 mo of placebo suppl patient 14 Human blood mononuclear leukocytes after 6 mo of placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of placebo supplementation mononuclear leukocytes treated 6mo Placebo group
GSM736016
GPL201
blood mononuclear leukocytes-after 6 mo of placebo suppl patient 15 Human blood mononuclear leukocytes after 6 mo of placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of placebo supplementation mononuclear leukocytes treated 6mo Placebo group
GSM736017
GPL201
blood mononuclear leukocytes-after 6 mo of placebo suppl patient 16 Human blood mononuclear leukocytes after 6 mo of placebo supplementation disease state: Alzheimers disease cell type: mononuclear leukocytes treatment: after 6 mo of placebo supplementation mononuclear leukocytes treated 6mo Placebo group
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes